搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按相关度排序
按时间排序
protothema.gr
6 天
Italy’s tourism minister is put on trial for falsifying her balance sheet – The ...
The Minister is accused of falsifying the balance sheet of the publishing group Vizibilia, which she founded, and the first hearing has been set for 20 March in Milan ...
5 小时
on MSN
89bio director McWherter buys $99,850 in stock
These purchases signal continued confidence in 89bio's prospects, as the company continues its work in pharmaceutical ...
20 小时
Golden Buying Opportunity: Up To 9% Yields For Pennies On The Dollar
There are numerous blue-chip high-yield dividend growth REITs that are trading at steep discounts to their NAV. Learn more ...
2 天
2 Very Overrated And 2 Very Underrated Big Dividend Stocks
Discover high-yield stocks with strong fundamentals for attractive returns. Click for the undervalued picks you may want, and ...
21 小时
on MSN
CNN's net worth cut in half between 2021 and 2023, forensic economist reveals during ...
The CNN defamation trial with U.S. Navy veteran Zachary Young revealed a rare inside look at the network’s books that showed ...
accountingweb.co.uk
1 天
Simplifying the Charity SORP – Insights from the CEO of Aedon.Accounting
By Paul Foden, CEO of Aedon.Accounting/* *Inadvertently the SORP committee has produced a compliance monster.* ...
MiningNews.net
1 天
Capricorn buys Pilbara project as Creasy backs Peregrine
Pilbara explorer Peregrine Gold has improved its balance sheet, with main shareholder and ‘billionaire prospector' Mark ...
Mint
2 天
Reliance Industries Balance Sheet Annual
Total Liabilities Shareholders' Equity 17,55,986.00 16,07,431.00 14,99,665.00 13,21,212.00 ...
Yahoo Finance
2 天
Carvana Co. (CVNA)
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
4 小时
on MSN
Altimmune's SWOT analysis: pemvidutide potential drives stock outlook
Altimmune, Inc. (NASDAQ:ALT), a biopharmaceutical company with a market capitalization of $503.56 million focused on ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈